Resolution of Medical Issues through Products and Services
In relation to aging populations in advanced countries, in recent years the need has been growing to reduce healthcare costs and extend healthy lifespans. At the same time, the establishment of medical infrastructure is unable to keep pace with growing populations in emerging markets and developing countries, and some 400 million people around the world are not receiving necessary levels of healthcare*. Boosting access to healthcare services is therefore an issue.
Meanwhile, the Sustainable Development Goals (SDGs) adopted by the United Nations in September 2015 set targets for human health and welfare, prompting growing expectations for global companies to undertake initiatives to resolve medical issues.
Under these conditions, the in vitro diagnostics (IVD) domain, which plays an important role in disease prevention, early detection and determining courses of treatment, is expected to contribute to a healthy society by creating new value and solving healthcare issues, including the three most deadly infectious diseases (HIV/AIDS, tuberculosis, malaria).
* Source: WHO “Universal Health Coverage”
In line with our mission of “shaping the advancement of healthcare,” which is defined in the “Sysmex Way,” the corporate philosophy of the Sysmex Group, we are working to create new value in the IVD field. We believe our mission is to address the shared desire of people around the world to remain healthy.
In particular, resolving healthcare issues and improving access to healthcare through our business activities are linked with creating new technological and social value, thereby contributing to a sustainable society.
Since the time of our founding, we have expanded our product lineup and strengthened our services and support in response to testing needs, working to provide accurate test data swiftly. In recent years, we have been conducting research and development to create advanced, high-value testing and diagnosis technologies with a view to realizing personalized medicine. To boost access to healthcare in emerging markets and developing countries, we are promoting business activities aimed at raising local levels of healthcare.
By leveraging the unique technologies we have cultivated to date, as well as our global network, we will continue to contribute toward the development of healthcare and the healthy lives of people.